Diabetes Channel
Topics
Medications
Quicklinks
Related Channels

Avandamet and Pregnancy

Avandamet and Pregnancy Category C

The U.S. Food and Drug Administration (FDA) uses a pregnancy category system to classify the possible risks to a fetus when a specific medicine is taken during pregnancy. Pregnancy Category C is given to medicines that have not been studied in pregnant humans but do appear to cause harm to the fetus in animal studies. Also, medicines that have not been studied in any pregnant women or animals are automatically given a pregnancy Category C rating.
 
When rosiglitazone (one of the components of Avandamet) was given to pregnant rabbits and rats during mid-to- late pregnancy, it caused miscarriages and decreased the growth of the baby rabbits or rats. Rosiglitazone did not cause any problems to rats or rabbits when it was given early in pregnancy. However, it is important to note that animals do not always respond to medicines the same way that humans do. Therefore, a pregnancy Category C medicine may be given to a pregnant woman if the healthcare provider believes that the benefits to the pregnant woman outweigh any possible risks to the unborn child.
 

Recommendations for Avandamet and Pregnancy

If you are pregnant or thinking about becoming pregnant, let your healthcare provider know. Your healthcare provider will consider both the benefits and risks of Avandamet during pregnancy before making a recommendation for your particular situation.
 
Steps to Prevent or Delay Diabetic Nerve Damage

Avandamet Drug Info

Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.